Daily FNArena News - Australia

North American earnings dented James Hardie’s performance in the second quarter as cost pressures were elevated. Brokers believe the sell-off in the stock presents a buying opportunity.

Sales momentum at Domino’s Pizza slowed over the first weeks of FY19 while the numbers of stores being opened appear significantly behind schedule.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

Commonwealth Bank is moving back to being a retail and business bank and brokers welcome the potential for capital management down the track.

Unibail-Rodamco-Westfield has reiterated 2018 earnings guidance, with dilution from asset sales countering the accretion from the acquisition of Westfield.

The price ResMed is paying for MatrixCare is rich, although brokers accept the deal will significantly expand its offering in home health data analytics.

Another difficult year looms for Westpac and, while mortgage re-pricing should boost first half performance, slower wealth revenues and further customer remediation are likely to weigh.

After a soft FY18 result Orica expects ammonium nitrate volumes will improve. However, uncertainties over the Burrup plant weigh on the outlook.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.